Physician, a medical professor and attending pediatric surgeon Dr. Mark Holterman is unswerving in his approach to advancing medicine on a worldwide level.
Leveraging more than 25 years experience, Dr. Mark Holterman’s schedule takes in work as a Professor of Surgery and Pediatrics at the College of Medicine at the University of Illinois at Peoria. He also functions as an attending Pediatric General Surgeon at the Children’s Hospital of Illinois.
In addition, Dr. Mark Holterman manages Mariam Global Health, a firm that develops and executes scientific advances (https://www.crunchbase.com/person/dr-mark-holterman#/entity).
After graduating cum laude with a biology degree from Yale University, Holterman continued his education attaining a Masters Degree and Ph.D. at the University of Virginia.
He is a member of the American Diabetes Association (ADA) which carries out research and advocacy measures concerning diabetes treatment and cure. Diabetes has an impact on almost 30 million people in the United States.
The ADA recently revealed a joint initiative with Children’s Hospital Los Angeles which tackles the growing rate of type 2 diabetes that takes place in children and teenagers (MarkJHolterman.Strikingly). The two groups will offer programs that include day camps, church settings, and after-school programs.
For example, Camp PowerUp aims to get the children more involved in physical activities and instructs them on healthier food choices as a way to reduce their chances of developing diabetes.
Dr. Mark Holterman was also involved from the beginning with the Hannah Sunshine Foundation, which focuses on the use of cellular and regenerative therapies for children with rare illnesses.
A 23-year old woman named Sarah Hughes, badly affected with systemic juvenile idiopathic arthritis (SJIA), was one of three young people who motivated the foundation.
The disease, which is a subtype of juvenile idiopathic arthritis (JIA) involves organs such as the heart and lungs as well as the joints. SJIA is an autoimmune disease with no cure and affects 10 to 20 percent of children who have some type of JIA. Dr. Mark Holterman and his associates trust that early, forceful medical care for the patient be supported.
Dr. Mark Holterman has received the Innovative Research Award from the American Diabetes Association and has also written articles for Surgical Clinics of North America and the Journal of Pediatric Surgery.